NSAID-related gastrointestinal injury - Evidence-based approach to a preventable complication

被引：23

作者：

Fennerty, MB ^{[1
]}

机构：

[1] Oregon Hlth & Sci Univ, Sch Med, Div Gastroenterol, Portland, OR 97201 USA

来源：

POSTGRADUATE MEDICINE | 2001年 / 110卷 / 03期

关键词：

D O I：

10.3810/pgm.2001.09.1020

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

In the United States, an estimated 15 million to 20 million people use nonsteroidal anti-inflammatory drugs (NSAIDs) on a long-term basis. With such statistics, it is not surprising that the most common side effect, gastrointestinal mucosal injury, remains a clinically important issue. Fortunately, this complication is largely preventable. In this review, Dr Fennerty focuses on the epidemiology, pathogenesis, risk factors, prevention, and treatment of NSAID-induced gastrointestinal injury and provides the reader with the data necessary to select care that prevents it.

引用

页码：87 / +

页数：6

共 15 条

[1] Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. [J].

Bombardier, C ;

Laine, L ;

Reicin, A ;

Shapiro, D ;

Burgos-Vargas, R ;

Davis, B ;

Day, R ;

Ferraz, MB ;

Hawkey, CJ ;

Hochberg, MC ;

Kvien, TK ;

Schnitzer, TJ ;

Weaver, A .

NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1520-1528

[2] Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs [J].

Cryer, B ;

Feldman, M .

AMERICAN JOURNAL OF MEDICINE, 1998, 104 (05) :413-421

[3] RISK FOR SERIOUS GASTROINTESTINAL COMPLICATIONS RELATED TO USE OF NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A METAANALYSIS [J].

GABRIEL, SE ;

JAAKKIMAINEN, L ;

BOMBARDIER, C .

ANNALS OF INTERNAL MEDICINE, 1991, 115 (10) :787-796

[4] DUODENAL AND GASTRIC-ULCER PREVENTION WITH MISOPROSTOL IN ARTHRITIS PATIENTS TAKING NSAIDS [J].

GRAHAM, DY ;

WHITE, RH ;

MORELAND, LW ;

SCHUBERT, TT ;

KATZ, R ;

JASZEWSKI, R ;

TINDALL, E ;

TRIADAFILOPOULOS, G ;

STROMATT, SC ;

TEOH, LS .

ANNALS OF INTERNAL MEDICINE, 1993, 119 (04) :257-262

[5] Omeprazole compared with misoprostol for ulcers associated with nonsteroidal antiinflammatory drugs [J].

Hawkey, CJ ;

Karrasch, JA ;

Szczepanski, L ;

Walker, DG ;

Barkun, A ;

Swannell, AJ ;

Yeomans, ND .

NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (11) :727-734

[6] Risk of aspirin-associated major upper-gastrointestinal bleeding with enteric-coated or buffered product [J].

Kelly, JP ;

Kaufman, DW ;

Jurgelon, JM ;

Sheehan, J ;

Koff, RS ;

Shapiro, S .

LANCET, 1996, 348 (9039) :1413-1416

[7] COX-1-sparing NSAIDs - Is the enthusiasm justified? [J].

Peterson, WL ;

Cryer, B .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (20) :1961-1963

[8] NSAIDs, gastrointestinal injury, and cytoprotection [J].

Scheiman, JM .

GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 1996, 25 (02) :279-&

[9] MISOPROSTOL REDUCES SERIOUS GASTROINTESTINAL COMPLICATIONS IN PATIENTS WITH RHEUMATOID-ARTHRITIS RECEIVING NONSTEROIDAL ANTIINFLAMMATORY DRUGS - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J].

SILVERSTEIN, FE ;

GRAHAM, DY ;

SENIOR, JR ;

DAVIES, HW ;

STRUTHERS, BJ ;

BITTMAN, RM ;

GEIS, GS .

ANNALS OF INTERNAL MEDICINE, 1995, 123 (04) :241-249

[10] Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis - The CLASS study: A randomized controlled trial [J].

Silverstein, FE ;

Faich, G ;

Goldstein, JL ;

Simon, LS ;

Pincus, T ;

Whelton, A ;

Makuch, R ;

Eisen, G ;

Agarwal, NM ;

Stenson, WF ;

Burr, AM ;

Zhao, WW ;

Kent, JD ;

Lefkowith, JB ;

Verburg, KM ;

Geis, GS .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (10) :1247-1255

← 1 2 →